THE BIOLOGICAL MECHANISMS UNDERLYING THE DEVELOPMENT OF DIABETIC NEPHROPATHY

Diabetic nephropathy (DN) represents one of the most severe and progressive microvascular complications of diabetes mellitus, ultimately leading to chronic kidney disease and end-stage renal failure if left untreated. Despite decades of research, the biological mechanisms underlying its initiation and progression remain complex and multifactorial. This paper provides a comprehensive analysis of the cellular and molecular pathways that contribute to DN development, focusing on hyperglycemia-induced metabolic disturbances, oxidative stress, chronic inflammation, glomerular hemodynamic abnormalities, and epigenetic modifications. Persistent hyperglycemia triggers excessive production of advanced glycation end products (AGEs), activation of the polyol and hexosamine pathways, and protein kinase C (PKC) overexpression, all of which synergistically damage glomerular and tubular structures.

Oxidative stress, driven by mitochondrial dysfunction and NADPH oxidase activation, further amplifies renal injury by promoting endothelial dysfunction, mesangial expansion, and podocyte apoptosis. Concurrently, pro-inflammatory cytokines—including IL-1β, IL-6, TNF-α, and MCP-1—activate NF-κB–mediated pathways, creating a self-perpetuating cycle of inflammation and fibrosis within renal tissues. Altered intraglomerular pressure caused by dysregulation of the renin–angiotensin–aldosterone system (RAAS) accelerates basement membrane thickening and glomerulosclerosis, while loss of podocyte integrity contributes to proteinuria, the hallmark of DN. Epigenetic modifications such as DNA methylation and histone acetylation have recently been identified as key drivers of “metabolic memory,” explaining why renal damage continues even after glycemic control is achieved. By integrating contemporary (2020–2024) research findings, this paper delineates DN as an interplay between metabolic, hemodynamic, inflammatory, and epigenetic factors rather than a single-pathway disease.

Understanding these interconnected mechanisms is essential for developing targeted therapies capable of preventing, slowing, or reversing diabetic kidney damage.